MXCT

MaxCyte, Inc. · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-03-25

Figures on this page computed 2026-11-08 12:57 UTC

Last close

1.39USD

Market data, 2026-11-04

MXCT: weekly closes from 1.32 on 2026-08-14 to 1.39 on 2026-11-04, a move of +5.3%. Prices in USD.

Weekly closes, 2026-08-14 to 2026-11-04

Over that span: +5.3%

Except where said otherwise: 10-K for 2025, filed 2026-03-25

n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0001104659-26-034557
Reported in
USD
- computed
- 10-K for 2025, filed 2026-03-25
The filing itself
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001104659-26-034557
Reported in
USD
- 10-K for 2025, filed 2026-03-25
- 10-K for 2025, filed 2026-03-25
- 10-K for 2025, filed 2026-03-25
- 10-Q for 2025, filed 2026-08-13
- 10-K for 2025, filed 2026-03-25
- 10-Q for 2025, filed 2026-08-13
The filing itself
-135.1%Net margin
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001104659-26-034557
Reported in
USD
- 10-K for 2025, filed 2026-03-25
- 10-K for 2025, filed 2026-03-25
The filing itself
-109.5%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001104659-26-034557
Reported in
USD
- 10-K for 2025, filed 2026-03-25
- 10-K for 2025, filed 2026-03-25
The filing itself
0.10Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0001104659-26-034557
Reported in
USD
- 10-K for 2025, filed 2026-03-25
- 10-Q for 2025, filed 2026-08-13
The filing itself
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Growth is the furthest below its sector's middle: 0.35 against 0.50 on the market's range.

What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

Five bars, one line

lens 7 of 9

1.17x

2.09x

1.97x

1.46x

0.32x

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Filed2025

Market data2026-11-04

Each against its own average

5 of 5 read

Except where said otherwise: 10-K for 2025, filed 2026-03-25

Sales1.17x
Its own average over 10 years, 28.2M.
Profit2.09x
Its own average over 10 years, -21.3M.
Free cash flow1.97x
Its own average over 10 years, -18.4M.
Debt1.46x
Its own average over 7 years, 12.3M.
Price0.32x
Its own average over 6 years, 4. Market data, 2026-11-04

Profit is furthest from its own average, at 2.09 times.

The filed years, as a table

Each line is 100 at 2016-12-31, the first year we hold.

Filed year	Sales	Shares in issue
2016-12-31	100.0	100.0
2017-12-31	114.0	145.1
2018-12-31	135.8	152.7
2019-12-31	176.2	168.3
2020-12-31	213.3	207.3
2021-12-31	276.2	270.4
2022-12-31	360.7	303.4
2023-12-31	336.5	308.1
2024-12-31	314.8	312.8
2025-12-31	269.2	317.5

How sales was got

Source: filed
Statement: income
Fiscal year: 2025
Accession: 0001104659-26-034557
Reported in: USD

The filing itself

How shares in issue was got

Source: filed
Statement: income
Fiscal year: 2025
Accession: 0001104659-26-034557
Reported in: USD

The filing itself

Figures behind the shape

Growth

4.8%

faster is higher, placed against 4,950 companies as of 2026-11-07

Five-year revenue growth rate4.8%
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed
Five-year EPS growth raten/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed
One-year change in net income-8.7%
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Returns on capital

-26.0%

higher is higher, placed against 5,089 companies as of 2026-11-07

Return on invested capitaln/a
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001104659-26-034557
Reported in
USD
- 10-K for 2025, filed 2026-03-25
- 10-K for 2025, filed 2026-03-25
- 10-K for 2025, filed 2026-03-25
- 10-Q for 2025, filed 2026-08-13
- 10-K for 2025, filed 2026-03-25
- 10-Q for 2025, filed 2026-08-13
The filing itself
Return on equity-26.0%
Net Income / Shareholders' Equity x 100
Source
computed
Fiscal year
2025
Accession
0001104659-26-034557
Reported in
USD
- 10-K for 2025, filed 2026-03-25
- 10-Q for 2025, filed 2026-08-13
The filing itself
Return on assets-22.0%
Net Income / Total Assets x 100
Source
computed
Fiscal year
2025
Accession
0001104659-26-034557
Reported in
USD
- 10-K for 2025, filed 2026-03-25
- 10-Q for 2025, filed 2026-08-13
The filing itself

Margins

81.2%

wider is higher, placed against 3,412 companies as of 2026-11-07

Gross margin81.2%
Gross Profit / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001104659-26-034557
Reported in
USD
- 10-K for 2025, filed 2026-03-25
- 10-K for 2025, filed 2026-03-25
The filing itself
Operating margin-157.1%
Operating Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001104659-26-034557
Reported in
USD
- 10-K for 2025, filed 2026-03-25
- 10-K for 2025, filed 2026-03-25
The filing itself
Net margin-135.1%
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001104659-26-034557
Reported in
USD
- 10-K for 2025, filed 2026-03-25
- 10-K for 2025, filed 2026-03-25
The filing itself
Free cash flow margin-109.5%
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001104659-26-034557
Reported in
USD
- 10-K for 2025, filed 2026-03-25
- 10-K for 2025, filed 2026-03-25
The filing itself

Price

0.8x

cheaper is higher, placed against 4,362 companies as of 2026-11-07

Price to earningsn/a
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0001104659-26-034557
Reported in
USD
- computed
- 10-K for 2025, filed 2026-03-25
The filing itself
Price to book0.8x10-Q for 2025, filed 2026-08-13
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
Source
computed
Fiscal year
2025
Accession
0001104659-26-095971
Reported in
USD
- computed
- 10-Q for 2025, filed 2026-08-13
- computed
- 10-K for 2025, filed 2026-03-25
The filing itself
EV to EBITDAn/a
We do not hold this figure for this company, so there is nothing to place.
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001104659-26-034557
Reported in
USD
- computed
- 10-K for 2025, filed 2026-03-25
- 10-K for 2025, filed 2026-03-25
- 10-Q for 2025, filed 2026-08-13
- 10-K for 2025, filed 2026-03-25
The filing itself
Price to sales ratio4.0x
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
Source
computed
Fiscal year
2025
Accession
0001104659-26-034557
Reported in
USD
- computed
- 10-K for 2025, filed 2026-03-25
- 10-K for 2025, filed 2026-03-25
The filing itself

Safety

0.10

safer is higher, placed against 3,227 companies as of 2026-11-07

Debt to equity0.10
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0001104659-26-034557
Reported in
USD
- 10-K for 2025, filed 2026-03-25
- 10-Q for 2025, filed 2026-08-13
The filing itself
Current ratio8.3010-Q for 2025, filed 2026-08-13
Current Assets / Current Liabilities
Source
computed
Fiscal year
2025
Accession
0001104659-26-095971
Reported in
USD
- 10-Q for 2025, filed 2026-08-13
- 10-Q for 2025, filed 2026-08-13
The filing itself
Interest coveragen/a
We do not hold this figure for this company, so there is nothing to place.
Operating Income / Interest Expense
Source
computed
Fiscal year
2025
Accession
0001104659-26-034557
Reported in
USD
- 10-K for 2025, filed 2026-03-25
- 10-K for 2025, filed 2026-03-25
The filing itself
Altman Z-Score0.69
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
Source
computed
Taken on
2026-11-07
Reported in
USD
- Computed from the 10-K for 2025, filed 2026-03-25
- Computed from the 10-K for 2025, filed 2026-03-25
- Computed from the 10-K for 2025, filed 2026-03-25
- Computed from the 10-K for 2025, filed 2026-03-25
- Computed from the 10-K for 2025, filed 2026-03-25

What it pays out

n/a

We do not hold this figure for this company, so there is nothing to place.

more, and better covered, is higher, with no cohort held

Dividend yieldn/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed
Payout ration/a
We do not hold this figure for this company, so there is nothing to place.
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
Source
computed
Fiscal year
2025
Accession
0001104659-26-034557
Reported in
USD
- 10-K for 2025, filed 2026-03-25
- Computed from the 10-K for 2025, filed 2026-03-25
- 10-K for 2025, filed 2026-03-25
The filing itself
Dividend cover ration/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Share a finding

A link to the finding, not to you: it carries nothing about your account.